经皮冠状动脉介入治疗后双联抗血小板治疗中断的模式与结局 - Suppr | 超能文献

Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention.

作者信息

Franchi Francesco, Rollini Fabiana

机构信息

Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.

Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.

出版信息

JACC Cardiovasc Interv. 2022 Apr 25;15(8):807-809. doi: 10.1016/j.jcin.2022.02.048.

DOI:10.1016/j.jcin.2022.02.048

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后双联抗血小板治疗中断的模式与结局

JACC Cardiovasc Interv. 2022 Apr 25;15(8):807-809. doi: 10.1016/j.jcin.2022.02.048.

2

Outcome of Different Discontinuation Patterns of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

JACC Cardiovasc Interv. 2022 Jul 11;15(13):1386. doi: 10.1016/j.jcin.2022.05.017.

3

Short Dual Antiplatelet Therapy in High Bleeding Risk Patients: 1 Month or 3 Months?

JACC Cardiovasc Interv. 2023 Oct 23;16(20):2511-2513. doi: 10.1016/j.jcin.2023.08.037. Epub 2023 Oct 4.

4

DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.

Thromb Haemost. 2021 May;121(5):687-689. doi: 10.1055/s-0040-1721145. Epub 2020 Nov 19.

5

Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.经皮冠状动脉介入治疗后出血风险、双联抗血小板治疗停药和不良事件：PARIS 注册研究。

Circ Cardiovasc Interv. 2020 Apr;13(4):e008226. doi: 10.1161/CIRCINTERVENTIONS.119.008226. Epub 2020 Mar 27.

6

Aspirin-free strategy versus standard term dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.经皮冠状动脉介入治疗患者中无阿司匹林策略与标准短期双重抗血小板治疗的比较：随机对照试验的荟萃分析

Eur J Prev Cardiol. 2021 Oct 13;28(12):e25-e28. doi: 10.1177/2047487320925623.

7

Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial.新型血小板聚集功能检测指导下的稳定型冠状动脉疾病行经皮冠状动脉介入治疗患者的个体化抗血小板治疗：一项随机对照临床试验。

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):211-221. doi: 10.1093/ehjcvp/pvz059.

8

De-escalation versus shortening of dual antiplatelet therapy.双联抗血小板治疗的降阶梯与缩短疗程

Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):267-269. doi: 10.1093/ehjcvp/pvae019.

9

Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.经皮冠状动脉介入治疗后急性冠状动脉综合征患者双联抗血小板治疗持续时间的Meta分析。

Eur J Prev Cardiol. 2019 Mar;26(4):429-432. doi: 10.1177/2047487318795245. Epub 2018 Aug 28.

10

Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.PRECISE-DAPT 评分预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出血事件的临床价值：来自 SMART-DATE 随机试验的分析。

Circ Cardiovasc Interv. 2020 May;13(5):e008530. doi: 10.1161/CIRCINTERVENTIONS.119.008530. Epub 2020 May 1.

引用本文的文献

1

Temporal characteristics and associated factors of discontinuation and outcomes after percutaneous coronary intervention.经皮冠状动脉介入治疗后停药的时间特征及相关因素与结局

Front Pharmacol. 2024 Apr 9;15:1355231. doi: 10.3389/fphar.2024.1355231. eCollection 2024.

2

Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC-ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project.在中国，已经接受慢性 P2Y12 受体抑制剂治疗的非 ST 段抬高型急性冠脉综合征患者中，P2Y12 抑制剂再负荷与住院结局的关系：来自 CCC-ACS（改善中国心血管疾病治疗-急性冠脉综合征）项目的结果。

Eur J Med Res. 2023 Feb 2;28(1):59. doi: 10.1186/s40001-023-01025-6.